Hazel Senz was diagnosed with Stage IV lung cancer in March of 2014. She has been on a series of medications, including targeted therapy for her ALK mutation. She talks about her experience with research and clinical trials...
Linda Rengel talks about her diagnosis nearly three years ago, and how survivors and patients are benefiting from research and living well with lung...
